HTA of NIVATS Based on RWE
Recruiting now
Conditions studied: Lung Cancer
In brief
This research focuses on a Health Technology Assessment (HTA) of non-intubated video-assisted thoracic surgery (VATS) for lung nodules. Lung cancer, one of the most prevalent malignancies globally, has a high incidence and mortality rate, particularly in China. Traditional treatments like thoracotomy are highly invasive, while conventional thoracoscopic surgery can induce anesthesia-related complications. Non-intubated VATS offers a promising alternative by avoiding intubation and mechanical ventilation, thus reducing complications, anesthesia burden, and recovery time. The study aims to comprehensively assess the clinical effectiveness, safety, and economic viability of non-intubated VATS for lung cancer treatment through systematic literature reviews, real-world evidence (RWE), and cost-effectiveness analysis. The research will also explore patient preferences using discrete choice experiments (DCE). By evaluating this technology from a Chinese perspective, the study seeks to provide evidence-based recommendations for the broader adoption of non-intubated VATS in clinical settings.
Key facts
- Study ID
- NCT06574295
- Run by
- Fudan University
- People needed
- 400
- Starts
- 2024-08-20
- Expected to finish
- 2025-03-02
- Last updated by the study team
- 2024-08-27
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Experimental Group (Non-intubated Video-assisted Thoracic Surgery)：
- Patients diagnosed with pulmonary nodules or lung cancer who are scheduled for minimally invasive surgery (including wedge resection, segmentectomy, or lobectomy).
- Aged between 18 and 75 years, regardless of gender.
- Preoperative assessment indicates that the patient can tolerate non-intubated video-assisted thoracic surgery.
- The patient has signed an informed consent form and voluntarily agrees to participate in the study.
- Control Group (Intubated Video-assisted Thoracic Surgery)：
- Patients diagnosed with pulmonary nodules or lung cancer who are scheduled for minimally invasive surgery (including wedge resection, segmentectomy, or lobectomy).
- Aged between 18 and 75 years, regardless of gender.
- Preoperative assessment indicates that the patient can tolerate minimally invasive surgery.
- The patient has signed an informed consent form and voluntarily agrees to participate in the study.
You may not qualify if…
- Patients unable to provide sufficient preoperative and postoperative follow-up data.
- Pregnant or breastfeeding women.
- Patients with severe cardiopulmonary dysfunction preoperatively, making them unfit for surgery.
- Patients who have previously undergone surgery or radiotherapy in the same chest region.
- Patients with active infections or other severe comorbidities that may affect surgical outcomes.
- Patients with mental illness or cognitive impairment who cannot understand the study content or comply with follow-up requirements.
Where it is running
- School of Public Health, Fudan University — Shanghai, Shanghai Municipality, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.